Dermata Therapeutics prices USD 3.4 million private placement at USD 1.46 per share

PUBT · 2d ago
Dermata Therapeutics prices USD 3.4 million private placement at USD 1.46 per share
  • Dermata Therapeutics priced a private placement at-the-market under Nasdaq rules, issuing 2,293,608 common shares or pre-funded warrants.
  • Deal includes series E warrants for 2,293,608 shares, series F warrants for 2,293,608 shares; both at USD 1.46 exercise price.
  • Gross proceeds expected at about USD 3.4 million; warrant exercise could add about USD 6.7 million.
  • Closing expected Aug. 18, 2026, subject to customary conditions; warrants exercisable after stockholder approval.
  • CEO, CFO, other insiders participating at USD 1.47 per share; insider warrant exercise price set at USD 1.47.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dermata Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608170830ACCESSWRNAPR_____1207953) on August 17, 2026, and is solely responsible for the information contained therein.